• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Eli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment

    Eli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment

  2. AstraZeneca , Eli Lilly Form Alzheimer's Disease Treatment Alliance

    AstraZeneca , Eli Lilly Form Alzheimer's Disease Treatment Alliance

  3. Immune Pharmaceuticals Initiates Phase II Clinical Trial In Ulcerative Colitis

    Immune Pharmaceuticals Initiates Phase II Clinical Trial In Ulcerative Colitis

  4. Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca

    Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca

  5. Clinigen Group Buys Oncology Support Therapy from AstraZeneca - Update

    Clinigen Group Buys Oncology Support Therapy from AstraZeneca - Update

  6. ProNova SC360 Selected for New Proton Center in Biopolis Singapore

    ProNova SC360 Selected for New Proton Center in Biopolis Singapore

  7. Illumina Announces Strategic Partnerships with AstraZeneca , Janssen and Sanofi to Redefine Companion Diagnostics for Oncology

    Illumina Announces Strategic Partnerships with AstraZeneca , Janssen and Sanofi to Redefine Companion Diagnostics for Oncology

  8. ADR Shares End Lower; Oi Shares Active

    ADR Shares End Lower; Oi Shares Active

  9. SumTotal Announces Results for First Half of 2014; Achieves 89 Percent Growth in New Customer Cloud Bookings

    SumTotal Announces Results for First Half of 2014; Achieves 89 Percent Growth in New Customer Cloud Bookings

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.